Metraipolis › archive › dc_7dceb62e55a3

Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with… — Europe PMC PMID:42553256

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42553256
DOI
10.3389/fphar.2026.1830548
License (as archived)
solo-consultazione
Archived
2026-10-08T03:07:24.577Z
SHA-256 of the archived text
6fdb0fb4fac7012325e672ab1bcbf58115cc1b99e0b937bc0bfbbe7b6b756411
Stable URL of this page
https://metraipolis.com/documento/dc_7dceb62e55a3

How to cite

Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with… — Europe PMC PMID:42553256 — Europe PMC (en), https://europepmc.org/article/MED/42553256 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7dceb62e55a3 (Metraipolis archive dc_7dceb62e55a3, sha256 6fdb0fb4fac7012325e672ab1bcbf58115cc1b99e0b937bc0bfbbe7b6b756411)
BibTeX
@misc{dc7dceb62e55a3,
  title = {Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with… — Europe PMC PMID:42553256},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42553256},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7dceb62e55a3; sha256 6fdb0fb4fac7012325e672ab1bcbf58115cc1b99e0b937bc0bfbbe7b6b756411},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42553256. Agents can read the archived copy with the MCP tool read_document.